A U.S. Supreme Court decision last week about the Medicare disproportionate share adjustment percentage calculation will have little effect on hospitals currently in the 340B drug pricing program, experts say. It could mean, though, that some on the cusp of eligibility might not get the bump they need to qualify for 340B pricing.
Five of the six types of hospitals that may participate in 340B qualify in part based on their Medicare DSH adjustment percentage. Disproportionate share, children’s, and free-standing cancer hospitals must have a Medicare DSH adjustment percentage greater than 11.75%, and rural referral centers and sole community hospitals a percentage equal to or greater than 8.0%.
A U.S. Supreme Court decision last week about the Medicare disproportionate share adjustment percentage calculation will have little effect on hospitals currently in the 340B drug pricing program, experts say.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
